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The PC12 pheochromocytoma cell line responds to nerve growth factor (NGF) by exiting from the cell cycle and
differentiating to induce extending neurites. Cyclin D1 is an important regulator of G1/S phase cell cycle progression, and
it is known to play a role in myocyte differentiation in cultured cells. Herein, NGF induced cyclin D1 promoter, mRNA,
and protein expression via the p21RAS pathway. Antisense- or small interfering RNA to cyclin D1 abolished NGF-
mediated neurite outgrowth, demonstrating the essential role of cyclin D1 in NGF-mediated differentiation. Expression
vectors encoding mutants of the Ras/mitogen-activated protein kinase pathway, and chemical inhibitors, demonstrated
NGF induction of cyclin D1 involved cooperative interactions of extracellular signal-regulated kinase, p38, and phos-
phatidylinositol 3-kinase pathways downstream of p21RAS. NGF induced the cyclin D1 promoter via Sp1, nuclear
factor-B, and cAMP-response element/activated transcription factor sites. NGF induction via Sp1 involved the formation
of a Sp1/p50/p107 complex. Cyclin D1 induction by NGF governs differentiation and neurite outgrowth in PC12 cells.
INTRODUCTION
Cyclin D1 is a member of the cyclin-dependent kinase (Cdk)
family of serine/threonine kinases that play a pivotal role in
controlling progression through the cell cycle (Pines, 1991;
Motokura and Arnold, 1993). As the regulatory subunits of
the Cdks, cyclin D1 complexes with catalytic partners to
phosphorylate several different “pocket” proteins, including
the retinoblastoma protein pRB and the related proteins,
p107 and p130 (Beijersbergen et al., 1995; Mayol et al., 1995;
Weinberg, 1995). The role of cyclin D1 in cell cycle regulation
is complex. Antisense and immunoneutralizing experiments
have demonstrated that cyclin D1 is capable of promoting
G1 phase progression (Baldin et al., 1993; Quelle et al., 1993;
Resnitzky et al., 1994; Resnitzky and Reed, 1995), but over-
expression of cyclin D1 inhibits replicative DNA synthesis,
implying cyclin D1 conveys a G1/S phase checkpoint func-
tion (Pagano et al., 1994). Cyclin D1 blocks PCNA relocation
to the nucleus and subsequent binding to the replication
initiation complex, an event required for normal S phase
entry (Pagano et al., 1994). We and others have shown cyclin
D1 is expressed in the developing central nervous system
(Shambaugh et al., 1994; Watanabe et al., 1998b) with cyclin
D1 transcripts detected in the anterior forebrain, the poste-
rior midbrain, in the developing somites, and in the neural
tube (Stahl et al., 2006). Deletion of both alleles for the cyclin
D1 gene in transgenic mice resulted in failure of normal
retinal neural layer development and abnormalities of neu-
ral regeneration (Fantl et al., 1995; Sicinski et al., 1995b).
These studies emphasized the importance of the cyclin D1
protein in neural cell function.
NGF plays an important role in growth, differentiation,
and survival of sympathetic and sensory neurons, and it
promotes neuronal differentiation of PC12 cells (Greene and
Tischler, 1976; Levi-Montalcini, 1976; Chao, 1992). Cyclin D1
expression is induced in postmitotic neurons (Freeman et al.,
1994) and by nerve growth factor (NGF) in the PC12 rat
pheochromocytoma cell line (Tamaru et al., 1994; Yan and
Ziff, 1995). NGF treatment of PC12 cells lead to a decrease in
proliferation rate and DNA synthesis, and differentiation
into sympathetic neuron-like cells (Rudkin et al., 1989). NGF
is reported to induce cell cycle arrest in G0/G1 phase (Rud-
kin et al., 1989) or to increase the proportion of cells in G2
without affecting the proportion of cells in G0/G1 (Buchk-
ovich and Ziff, 1994). Activation of the tyrosine kinase
(Trk)A receptor by NGF induces p21RAS and sequentially
the activity of several distinct kinases, including the raf
kinases (B-raf), mitogen-activated protein kinase kinase
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(MEK)1, extracellular signal-regulated kinases (ERKs), phos-
phatidylinositol 3-kinase (PI3K), phospholipase C, and ri-
bosomal S6 kinases (pp90RSK) (Thomas et al., 1992; Stephens
et al., 1994). Activation of p21RAS or overexpression of MEK
induces neurite outgrowth in PC12 cells (Bar-Sagi and Fera-
misco, 1985; Guerrero et al., 1986; Fukuda et al., 1995), and
dominant-negative p21RAS expression vectors blocked NGF-
induced neurite outgrowth (Szebere´nyi et al., 1990; Thomas
et al., 1992; Wood et al., 1992; Cowley et al., 1994). Thus,
p21RAS is capable of inducing a cascade of signaling events
that lead to PC12 differentiation; however, the mechanisms
leading to exit from the cell cycle and differentiation remain
to be elucidated.
Neuronal outgrowth mediated by NGF requires p21RAS,
and it is associated with activation of the serine threonine
kinases, ERKs. ERKs are induced by dual phosphorylation
on threonine and tyrosine residues by MEKs (Cobb and
Goldsmith, 1995; Marshall, 1995). Overexpression of p21RAS,
p74RAF, MEK, and ERK are capable of inducing neurite out-
growth in PC12 cells, although ERK activation by growth fac-
tors may not be sufficient for the induction of neurite out-
growth (Bar-Sagi and Feramisco, 1985; Guerrero et al., 1986;
Szebere´nyi et al., 1990; Cowley et al., 1994; Jaiswal et al., 1994;
Lange-Carter and Johnson, 1994; Vaillancourt et al., 1995).
NGF induces a Ras-dependent pp90RSK kinase, which phos-
phorylates cAMP response element-binding protein (CREB)
(Ginty et al., 1994). CREB binding sites are required for full
NGF response of the immediate early genes ziff 268 (De-
Franco et al., 1993), nur77 (Yoon and Lau, 1993), the c-fos
promoter (Ginty et al., 1994), and the neuronal secretory
protein VGF (Hawley et al., 1992). For the c-fos promoter,
NGF induction requires cooperation between a CREB bind-
ing site and a transcription factor bound to the serum re-
sponse element (SRE) (Ginty et al., 1994).
The molecular mechanisms governing the genomic re-
sponses that occur after the delayed early genes, preceding
and concordant with differentiation and exit from the cell
cycle are currently an area of considerable interest. In the
studies described herein, the intracellular signaling path-
ways governing NGF induction of cyclin D1 expression was
determined in PC12 cells. As cyclin D1 was induced by NGF,
we assessed the effect of either ectopic overexpression or
antisense cyclin D1 on NGF-mediated neurite outgrowth.
Cyclin D1 is required for NGF-mediated neurite outgrowth
in PC12 cells.
MATERIALS AND METHODS
Cell Cultures and Treatment
PC12 and PC12-DN-RAS (M-M17-26) cells were maintained in DMEM (In-
vitrogen, Carlsbad, CA) containing 10% defined and supplemented calf se-
rum, 5% equine serum (heat-inactivated; Invitrogen), 10% glutamine, and 100
mg/ml penicillin and streptomycin, in a humidified 37°C incubator. Cells
were plated on poly-l-lysine–coated dishes at the density of 2  106 cells/
10-cm dish and starved for 24 h with 1% equine serum before all experiments.
NGF (2.5S, murine NGF; Promega, Madison, WI) was used at 50 ng/ml. The
MEK inhibitor PD098059 at 30 mM was a gift from Dr. A Saltiel (Life Sciences
Institute, University of Michigan, Ann Arbor, MI). The p38 inhibitor SB203580
at 10 mM was supplied by SmithKline Beecham (Worthing United Kingdom).
Wortmannin (200 nM) was supplied by Calbiochem (San Diego, CA), and
neomycin (Invitrogen) was reconstituted and stored as recommended by the
manufacturer.
Determination of Neurite Extension
The differentiation state of PC12 cells was determined by counting neurite-
bearing cells with neurite length at least twice that of the cell body (Boulukos
Figure 1. Cyclin D1 induction by NGF is Ras dependent.
(A) Top, cell lysates from PC12 cells untreated (0) or treated
with 25, 50, or 75 ng/ml NGF for the indicated times were
analyzed by immunoblotting with specific antibodies for the
indicated proteins. Bottom, densitometric analysis of cyclin
D1 expression versus the amount of -tubulin. (B) Immuno-
histochemical staining of PC12 cells was performed using
the cyclin D1-specific antibody in randomly cycling cells
(bottom) or in the cells that were serum starved (top) for 48 h
before the addition of 50 ng/ml NGF for 3 or 8 h. (C) Cell
lysates from PC12 and dominant-negative p21RAS N17cell
line (M-M17-26) untreated () or treated () with 50 ng/ml
NGF for the indicated times were analyzed by immunoblot-
ting with specific antibodies for the indicated proteins.
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and Ziff, 1993). The level of neurite extension was calculated as the percentage
of neurite-bearing cells relative to the total number of cells analyzed.
Immunohistochemical Staining and Western Blotting
Immunohistochemistry was performed using the cyclin D1 antibody DCS-6
(Novacastra Laboratories, Vector Laboratories, Newcastle upon Tyne, United
Kingdom). For the immunoblot analysis, cells were lysed and sonicated for
30 s in 2% SDS containing phosphatase and protease inhibitors. Protein
concentration was assessed using the Bio-Rad protein assay (Bio-Rad, Her-
cules, CA), and equal amounts were separated by SDS-polyacrylamide gel
electrophoresis (PAGE). The proteins were transferred to a nitrocellulose
membrane by electroblotting. Immunoblotting were performed with the fol-
lowing antibodies: cyclin D1 (05–815) was provided by Upstate Biotechnol-
ogy (Charlottesville, VA), -tubulin (sc-5546), phospho-ERK (sc-7383), total-
ERK (sc-154), nuclear factor-B (NF-B) (p50) (sc-1190), p107 (sc-318), Sp1
(sc-420), c-Myc (sc-042), c-Jun (sc-1694), c-Fos (sc-52), CREB (sc-25785), and
-tubulin (sc-58668) were from Santa Cruz Biotechnology. Peroxidase-conju-
gate anti-mouse or anti-rabbit immunoglobulin G (Santa Cruz Biotechnology)
was used for enhanced chemiluminescence detection.
Immunoprecipitation
PC12 cells were solubilized in lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM
NaCl, and 0.5% Triton X-100) in the presence of protease inhibitors at 4°C for
30 min. Insoluble debris was removed by microcentrifugation at 11,000  g
for 5 min. Proteins were immunoprecipitated by incubation in the presence of
specific antibodies for 1 h at 4°C, followed by adsorption on protein G-
Sepharose (GE Healthcare, Chalfont St. Giles, United Kingdom), and sub-
jected to further Western blot analyses.
Construction of Plasmid Vectors
The 5 promoter luciferase reporter constructions derived from the human
cyclin D1 genomic clone have been described previously (Albanese et al., 1995;
Watanabe et al., 1996b). Several heterologous constructions were made in
which cyclin D1 promoter enhancer sequences were linked to the thymidine
kinase (TK81) promoter (TK81pA3LUC) and include CD1(AP-1)TKLUC (the
cyclin D1 activator protein AP-1 site from 963 to 940), CD1(E2F)TKLUC
(the cyclin D1 sequences from 156 to 133), and CD1(CRE)TKLUC (se-
quences from 66 to 40). The nur77 reporter (nur77LUC) encodes the
NGF-responsive sequences of the nur77 promoter from 86 to 122
(86wtLUC) (Yoon and Lau, 1994). The c-fos promoter from 361 to 157,
cloned by polymerase chain reaction (PCR) using oligodeoxyribonucleotide
probes to the published sequence and human genomic DNA, was subcloned
into the pA3LUC reporter. The 5 oligo primer sequence was 5-GGT ACC
GCC CGC GAG CAG TTC CCG-3, and the 3 oligo sequence was 5 AAG
CTT CGT GGC GGT TAG GCA AAG 3. The c-fos SRE sequence (333 to
291) was linked to the minimal E1BTATALUC to form SRETATALUC. The
c-Myc P1 and P2 promoters from 157 to 500 (DesJardins and Hay, 1993)
were linked to the pA3LUC reporter to form P1P2MycLUC. The P2 promoter
derived from 66mycCAT (DesJardins and Hay, 1993) was cloned into the
pA3LUC reporter to form P2MycLUC. The cyclin A promoter construction
(Henglein et al., 1994) and the c-Jun-responsive reporter containing three AP-1
sites, p3TP-LUX, were described previously (Pestell et al., 1994b; Pestell et al.,
1995). The reporter (UAS)5E1BTATALUC consists of the (UAS)5E1BTATA
sequences from Gal5CAT cloned into the reporter pA5LUC (Watanabe et al.,
1996b).
Expression Vectors
The plasmids RSV Ras L61 (Leu 61) (oncogenic p21RAS), RSV Ras L61 S186
(Leu 61, Ser 186), (encoding oncogenic p21RAS without the membrane target-
ing motif), RSV Ras N17 (the dominant interfering p21RAS, Ras Asn17), RSV
Neo, and EXV Ras Val 12 (oncogenic p21RAS) were described previously
(Pestell et al., 1996a). The dominant-negative MEK was obtained through a
double Ser-Ala mutation to give Exv MEK-c (Ala218/Ala222) (Qiu et al., 1995)
(a generous gift from Dr. S. McDonald, Onyx Pharmaceuticals, Richmond,
CA). pCMV-p41MAPK, (ERKwt) pCMV-p41(Ala54 Ala55)MAPK (ERKmt) (Seth
et al., 1992), and the dominant-negative ERK expression vector (ERKi) were
described previously (Conrad et al., 1994). The cyclin D1 cDNA was isolated
as an EcoR1 fragment from the vector pPL-8 (Motokura et al., 1991) and
cloned in either the sense or antisense orientation into the vector pUHD10.3
(Gossen and Bujard, 1992; Resnitzky et al., 1994) to form the vectors
pUHDCD1(s) and pUHDCD1(as). The tetracycline-regulated pUHD15–1neo
carries a neomycin resistance gene and a chimeric gene encoding a fusion
product between the tetracycline repressor (tetR) of the Tn10 tetracycline-
resistance operon of Escherichia coli and the activating domain of virion
protein 16 (VP16) of herpes simplex virus. The cyclin D1 cDNA insert was
also introduced into the tet-regulated vector pBPSTR-1 (Paulus et al., 1996) in
the antisense orientation to form pBPSTR-1CD1(as). The plasmids Gal4-Sp1,
Gal4-p107, Gal4-p107mut, and Gal4-p50 were used in conjunction with the
(UAS)5E1BTATA luc reporter (Watanabe et al., 1996a). The sequence of the
cyclin D1 promoter E2F site, Sp1 site, and CRE site (Watanabe et al., 1996b)
was previously described. For construction of the vector E2FTKLUC and
E2FmTKLUC the oligodeoxyribonucleotide containing the wild-type (Yee et al.,
1987) and mutant E2F sites (Weintraub and Dean, 1992) from the adenovirus E2a
promoter were synthesized as complementary strands and cloned into BamH1-
restricted TK81pA3LUC to form E2FTKLUC (Watanabe et al., 1998a).
Transfections and Infection
PC12 cells were plated 24 h before the transfection at a density of 80,000
cells/cm2. The formulation of lipid–DNA or –small interfering RNA (siRNA)
complexes was prepared by diluting siRNA and Lipofectamine 2000 reagent
(Invitrogen) according to the manufacturer’s instructions. The Lipofectamine
2000–siRNA or -DNA complexes were then gently layered on the cultured
cells. After 24 h, the cells were split onto poly-l-lysine–coated dishes, and
then they were treated with 50 ng/ml NGF after 24 h. siRNAs against
rat cyclin D1, p107, and Sp1 were purchased from QIAGEN (Valencia,
CA), and p50-siRNA was purchased from Santa Cruz Biotechnology. The
-1745CD1LUC reporter was introduced into exponentially growing PC12 cells
by transfecting 2 g of -1745CD1LUC and 400 ng of pCDNA3 (Invitrogen) per
100-mm plate using the calcium phosphate precipitation technique. Stable
transformants were selected using Geneticin (Invitrogen). Resistant cells were
subcloned, and the cell lines -1745CD1PC12.5 and -1745CD1PC12.8 were
selected. The Ras N17 stable PC12 cell line M-M17-26 was described previ-
ously (Szebere´nyi et al., 1990). Retroviral infection was conducted as described
previously (Neumeister et al., 2003).
Electrophoretic Mobility Gel Shift Assays (EMSAs)
EMSAs using cellular nuclear extracts or in vitro-translated proteins were
performed essentially as described previously (Pestell et al., 1994a; Albanese
et al., 1995). For EMSA, 5–10 g of nuclear extracts was used in binding buffer
containing 20 mM HEPES, pH 7.4, 40 mM KCl, 1 mM MgCl2, 0.1 mM EDTA,
and 0.1% NP-40 to which 0.5 ng of -32P–labeled probe and either 50 g/ml
poly(dI-dC), or for the E2F gel-shifts, 2 g of sonicated salmon sperm DNA,
as competitor, was added. Supershifts were performed with antibodies to
c-Jun (sc-822X), ATF-2 antibody (sc-187), and a c-Fos antibody (sc-253X)
purchased from Santa Cruz Biotechnology and a CREB antibody that is also
Figure 2. NGF inhibits proliferation and induces cell cycle arrest in
a Ras-dependent manner. (A) Growth curve of PC12 and PC12
(M-M17-26) cells counted at the indicated times. The data represent
the mean SEM from n 3 experiments. (B) FACS analysis of PC12
and PC12 (M-M17-26) cells treated () and untreated () with 50
ng/ml NGF for 14 d.
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immunoreactive with cAMP response element modulator (CREM) (HM93). The
ziff268 antibody was a gift from Dr. L. Lau of the Johns Hopkins University
School of Medicine (Williams and Lau, 1993). The reaction products were sepa-
rated on 4% polyacrylamide gel run in 0.25 x Tris-borate-EDTA at 4°C at 180 v for
2–3 h. The gels were dried and exposed to XAR5 (Kodak) radiographic film.
Reverse Transcriptase (RT)-PCR
Cyclin D1 mRNA expression was determined by a qualitative RT-PCR
assay. Total RNA was obtained from the PC12 or PC12 DN-RAS (M-M17-
26) cells by using the RNAeasy Plus mini kit (QIAGEN). RNA levels and
purity were assessed. The quantitative RT-PCRs were done using the
Access RT-PCR System (Promega). Primer sequences were as follows:
cyclin D1 Fwd, 5-TGGAGCCCCTGAAGAAGAG-3 and cyclin D1, Rwd
5-AAGTGCGTTGTTGTGCGGTAGC-3; and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) Fwd, 5-ACGACCCCTTCATTGACCTC-3 and
GAPDH Rwd, 5-GGGGGCTAAGCAGTTGGTGG-3. PCR products were
analyzed on a 1.5% agarose gel.
p42ERK p44ERK and SAPK Immune-Complex Assays
Assays were performed as described previously (Pestell et al., 1996b) on cell
extracts from PC12 cells treated with 20 ng/ml NGF or with vehicle. For
assays, staphylococcal protein A-Sepharose beads were incubated with anti-
mitogen-activated protein kinase (MAPK) antibody (C16) (Santa Cruz Bio-
technology), anti-stress-activated protein kinase (SAPK) antibody for 1 h at
4°C. The antibody and beads were washed once with radioimmunoprecipi-
tation assay (RIPA) buffer, and then they were incubated with cell lysates for
2 h at 4°C. The immunoprecipitates were washed with RIPA buffer once, with
LiCl/0.1 M Tris base, pH 8.0, twice, and once in kinase buffer. The kinase
reactions were performed at room temperature for 20 min in 30 ml of kinase
buffer with 10 mCi of [-32P]ATP (3000 Ci/mmol; 1 Ci  37 GBq) and 4 mg
of myelin basic protein (MBP) or 4 mg of c-Jun fusion protein for SAPK
assays. The samples were analyzed by SDS-PAGE upon termination of the
reaction with Laemmli buffer and boiling. The phosphorylation of MBP or
c-Jun was quantified by densitometry using a Fuji Bio Imaging Analyzer BAS
2000 (Fuji Photo Film, Kanagawa, Japan).
Chromatin Immunoprecipitation (ChIP) Assay
Cells were cultured for 24 h without NGF or with NGF 50 ng/ml. Formal-
dehyde was added to the cells to a final concentration of 1%, and then the cells
were incubated at 37°C for 10 min. Cells (5  106) were collected, and ChIP
assay was performed using the EZ-Magna Chip (Upstate Biotechnology, Lake
Placid, NY) following the manufacturer’s instructions. The cell lysate was
sonicated to generate DNA fragments with an average length of 200-1000 bp.
Genomic DNA enriched by antibody against Sp1 (sc-420; Santa Cruz Biotech-
Figure 3. Ectopic expression of anti-sense or siRNA to cyclin D1 blocks NGF induction of neurite outgrowth in PC12 cells. (A) PC12 cells
transfected with either control vector, cyclin D1 sense, cyclin D1 antisense, siRNA control, or siRNA cyclin D1 were either untreated () or
treated () for 72 h with NGF, and they were subsequently photographed using a phase-contrast microscope. (B) The same cells were
analyzed for neurite length. (C) Cell lysates from the cells presented in A were analyzed by cyclin D1 immunoblotting to verify knockdown
and stimulation with NGF. (D) Growth curve of PC12 cells transfected with control vector, cyclin D1 sense, and cyclin D1 antisense for the
indicated times.
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nology) was purified by phenol extraction. Immunoprecipitated DNAs were
subjected to PCR amplification (35 cycles of 95°C for 20 s, 64°C for 20 s, and
72°C for 1 min) of the cyclin D1 promoter by using specific forward (5-
TTCTCTGCCCGGCTTTGATCTC-3) and reverse (5-CTCTCTGCTACTGCGC-
CAACA-3) primers from Takasawa et al. (2006), to amplify the promoter region
(92 to 27 nucleotides in relation to the transcription start site). The PCR
products were resolved by electrophoresis on a 2% agarose gel and visualized
after ethidium bromide staining. As a control for DNA content, PCR reactions
were also performed on chromatin samples before immunoprecipitation (input).
Cell Proliferation Assay and Fluorescence-activated Cell
Sorting (FACS) Analysis
PC12 cells were counted using a hemocytometer, and then tested for exclu-
sion of trypan blue. Data are expressed as average of triplicate  SEM. PC12
cells were harvested by trypsin-EDTA and washed; pellets were resuspended
in 0.3 ml of 50% fetal calf serum in phosphate-buffered saline, treated with 0.9
ml of 70% ethanol, and left overnight in the dark at 4°C before FACS analysis
(FACSCaliber; BD Biosciences, San Jose, CA) as described previously (Rao et
al., 2007).
RESULTS
NGF Induction of Cyclin D1 Requires p21RAS in PC12
Cells
We first determined the concentration of NGF request to
induce cyclin D1, based on the concentration known to
induce PC12 cellular differentiation. Time course experi-
ments were conducted using several concentrations of NGF
(25, 50, or 75 ng/ml). Cyclin D1 was induced at each NGF
concentration, and 50 ng/ml was used in subsequent anal-
ysis (Figure 1A). Immunohistochemical studies were per-
formed using the cyclin D1-specific antibody to determine
the effect of NGF on cyclin D1 abundance. Serum-starved
PC12 cells were treated with NGF for 3 and 8 h. The abun-
dance of cyclin D1 was low in serum-starved cells, and it
was induced by NGF in most cells within 8 h (Figure 1B). In
serum-replete conditions, the nuclear abundance of cyclin
D1 varied between cells, consistent with previous observa-
tions that the nuclear abundance of cyclin D1 varies
throughout the cell cycle. Treatment with NGF for 8 h in-
duced nuclear staining for cyclin D1 in 	95% of the cells
(Figure 1B).
Because NGF regulates the TrkA/p21RAS pathway, we
investigated whether NGF induced cyclin D1 expression via
p21RAS. A time course experiment was conducted in pres-
ence or absence of 50 ng/ml NGF by using PC12 cells, and
the PC12 dominant-negative Ras stable cell line M-M17-26
(Szebere´nyi et al., 1990). NGF induced cyclin D1 in PC12 cells
and activated ERK, whereas the same treatment did not
affect cyclin D1 abundance or ERK activation in the Ras
dominant-negative PC12 (M-M17-26) (Figure 1C).
To determine the effect of NGF on growth and cell cycle
distribution of PC12 and Ras dominant-negative PC12 cells
Figure 4. NGF stimulates cyclin D1 pro-
moter activity. (A) Dose response for NGF
(1–50 ng/ml) in PC12 cells stably transfected
with the -1745 CD1LUC reporter. The data
represent the mean  SEM of n  6 separate
transfections. (B) Time course assessment of
NGF induction of -1745 CD1LUC reporter ac-
tivity. The mean data SEM of n 6 separate
transfections are shown. (C) NGF induction of
-1745CD1Luc reporter promoter activity was
assessed in PC12 cells or in the PC12 (M-M17-
26) (D) The dominant-negative p21ras (Ras
N17) or activating p21ras mutants (RasL61)
were transfected into the -1745 CD1LUC PC12
cells. NGF induction of promoter activity was
assessed following 12 h of stimulation (50 ng/
ml). The p21ras mutant RasL61 is incapable of
inserting in the plasma membrane. The mean
data SEM of n 5 separate transfections are
shown. Data were normalized to the control
(empty expression vector). (E) RT-PCR analy-
sis performed on PC12 and PC12 (M-M17-26)
cells, untreated () or treated () with 50
ng/ml NGF for indicated times by using spe-
cific primers for cyclin D1.
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(M-M17-26), cellular proliferation and FACS analysis were
conducted. NGF treatment induced growth arrest of PC12
cells, whereas proliferation of the Ras dominant-negative
PC12 cells (M-M17-26) was unaffected by NGF treatment
(Figure 2A). FACS analysis was conducted after 14 d of NGF
treatment. NGF treatment increased the proportion of PC12
cells in the G0/G1 phase and reduced the number of cells in
the G2/M phase, whereas the cell cycle distribution in the
Ras dominant-negative PC12 cells (M-M17-26) was not af-
fected (Figure 2B). Together, these results indicate that the
activation of TrkA-p21RAS pathway by NGF is essential to
induce cyclin D1 expression, growth arrest, and differentia-
tion.
Cyclin D1 Is Required for Full NGF-induced Neurite
Outgrowth
To study the functional significance of cyclin D1 in NGF-
induced differentiation, we knocked down cyclin D1 and
assessed neurite outgrowth. PC12 cells were infected with a
cyclin D1 cDNA sense or antisense expression vector under
control of the tetracycline-regulated promoter (Tet-Off), or
they were transfected with cyclin D1 siRNA. Expression of
cyclin D1 antisense efficiently reduced NGF-induced neurite
outgrowth, whereas the overexpression of cyclin D1 alone
did not affect neurite outgrowth irrespective of NGF stimu-
lation (Figure 3, A and B). The relative length and number of
neurites were also reduced in the cyclin D1 siRNA PC12-
transfected cells treated with NGF (Figure 3, A and B).
Immunoblotting analysis verified the transfection efficiency
and the reduction in cyclin D1 abundance (Figure 3C). To
determine the effects of cyclin D1 on PC12 cellular growth,
proliferation analysis was conducted in PC12 cells infected
with a cyclin D1 cDNA sense or antisense expression vector.
Expression of cyclin D1 antisense reduced PC12 cellular
proliferation. Thus, cyclin D1 is essential for the mainte-
nance of PC12 cell proliferation potential, and it is essential
for the NGF-induced neurite outgrowth. Cyclin D1 overex-
pression alone is not sufficient to induce differentiation.
NGF Stimulates Cyclin D1 Promoter Activity and mRNA
Synthesis through p21RAS
Further studies were conducted to determine the mecha-
nism by which NGF induces cyclin D1. A 1745-base pair
cyclin D1 promoter fragment linked to luciferase gene was
transfected into PC12. The concentration of NGF required
for maximal induction of the -1745CD1LUC reporter in PC12
cells was determined using increasing doses of NGF for 24 h.
Maximal (6-fold) induction of the cyclin D1 promoter was
observed with NGF at a concentration of 50 ng/ml (Figure
4A). A time course experiment demonstrated that the cyclin
D1 promoter was induced maximally (3- to 6-fold) by NGF,
and it peaked at 6 h (Figure 4B). To determine whether the
NGF effects on endogenous cyclin D1 transcripts levels were
dependent upon p21RAS, we used three different ap-
proaches. First, we analyzed the cyclin D1 promoter activa-
tion by NGF treatment in M-M17-26-PC12 cells. NGF-in-
duced cyclin D1 promoter activity was reduced 70% in the
PC12-M-M17-26 (Figure 4C). The role of Ras was also exam-
ined through coexpression of the dominant-negative mutant
Ras N17 in transient expression studies. NGF-induced activ-
ity of the -1745CD1LUC reporter was reduced 60% by Ras
N17 (Figure 4D). Activating p21RAS mutants (RasL61 and
RasV12) were overexpressed in PC12 cells in conjunction
with the -1745CD1LUC reporter to determine whether p21RAS
was sufficient for induction of the cyclin D1 promoter in PC12
cells. RasL61 induced -1745CD1LUC reporter activity sixfold
(Figure 4D), and RasV12 induced -1745CD1LUC reporter ac-
tivity fivefold (data not shown). The addition of 50 ng/ml
NGF induced the cyclin D1 promoter a further twofold in
the presence of RasL61 (Figure 4D). Quantitative RT-PCR
assay of mRNA levels in PC12 and M-M17-26-PC12 cells
treated or untreated with 50 ng/ml NGF demonstrated NGF
induced cyclin D1 mRNA in the PC12 cells but not in the Ras
dominant-negative PC12 cells (M-M17-26) (Figure 4E).
Previous studies demonstrated that NGF induced expres-
sion of several immediate early genes, including c-fos, nur77,
and c-myc in PC12 cells (Greenberg et al., 1985). The effect of
NGF on these genes promoters was assessed using PC12 and
Ras dominant-negative PC12 cells (M-M17-26) transfected
with the promoter of c-fos, nur77, c-myc, cyclin A, or pA3
linked to the luciferase gene. The c-fos promoter was stim-
ulated fivefold at 6 h, the c-myc promoter was induced
4.5-fold, and the nur77 promoter reporter was induced four-
fold (Figure 5A). In contrast, the plasmid pA3LUC and the
cyclin A LUC reporter were not induced by NGF, indicating
the induction of the cyclin D1 promoter by NGF was gene-
dependent (Figure 5A). Compared with the wild type PC12
cells, the induction by 50 ng/ml NGF in the M-M17-26 cells
was reduced for c-fosLUC from eightfold to twofold, and for
c-mycLUC from fourfold to twofold, consistent with previ-
ous studies demonstrating the importance of the Ras path-
way in NGF-induced c-fos promoter activity (Ginty et al.,
1994). The induction of the nur77 promoter was maintained
in the M-M17-26 cells (Figure 5A), consistent with previous
observations in which the induction of nur77 mRNA was
unchanged in M-M17-26 cells (Szebere´nyi et al., 1990). Be-
cause previous studies demonstrated a role for p21RAS in
c-fos induction by NGF (Ginty et al., 1994), experiments were
conducted with the c-fosLUC reporter. RasL61 induced the
c-fosLUC reporter threefold and overexpression of RasN17
reduced NGF induced c-fosLUC activity 60% (data not
shown). We next determined the effect of NGF on c-Myc,
Figure 5. p21RAS modulates NGF induction of the cyclin D1 pro-
moter. (A) The effect of 50 ng/ml NGF for 12 h on the cyclin D1
promoter and the promoter of several immediate early genes was
determined in PC12 and PC12 (M-M17-26) cells. The mean data 
SEM of n  9 separate transfections are shown. Data were normal-
ized to the control (empty expression vector). (B) Cell lysates from
PC12 and PC12 (M-M17-26) cells untreated () or treated () with
50 ng/ml NGF for the indicated times were analyzed by immuno-
blotting with specific antibodies for indicated proteins.
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c-Fos, and c-Jun protein expression. As show in Figure 5B,
NGF induced a sustained expression of c-Fos, c-Jun, and
CREB, a transient expression of c-Myc in PC12 cells, and no
modulation of these proteins occurred in M-M17-26 cells.
ERK, p38, and PI3K Pathways Are Required for Full NGF
Induction of Cyclin D1
Ras is known to mediate several different pathways in re-
sponse to epidermal growth factor (EGF), including the
ERKs, Raf-1, and the RSK kinases (Wood et al., 1992). To
characterize the intracellular signaling pathways involved in
NGF-induced cyclin D1 promoter activity, MAPK assays
were performed on NGF treated PC12 cells. NGF-induced
ERK activity eightfold in 10 min, and ERK activity remained
elevated at 2 h. ERK activity had returned to basal at 6 h
(Figure 6A). SAPKs were induced fourfold at 10 min, as
described previously (Szebere´nyi et al., 1990) (Figure 6B).
To investigate the role of the MEK/ERK, p38 and PI3K
pathways in basal and NGF induced expression of cyclin D1,
-1745CD1LUC–transfected PC12 cells were treated with
NGF either alone or with the addition of the MEK
(PD98059), p38 (SB203580), or PI3K (wortmannin) inhibitors.
Furthermore, PC12 cells were cotransfected with the domi-
nant-negative mutants of MEK (MEK-C), ERK (MAPKi), or
with SAPK/ERK kinase (SEK) dominant-negative mutants
(SEKKR and SEKAL). Luciferase activity was assessed after
24 h of treatment. As shown in Figure 6C, both the MEK,
p38, and PI3K inhibitors and MEK-C, or MAPKi reduced the
NGF-induced cyclin D1 promoter activity 40% (PD98059),
68% (SB203580), 70% (wortmannin), 80% (dominant-nega-
tive MEK), and 50% (dominant-negative ERKs), respec-
tively. Conversely, the cyclin D1 promoter activity was not
affected by overexpression of the SEK dominant-negative
mutants SEKKR or SEKAL.
Because p21RAS controls activation of the PI3K and ERK
pathways, we investigated the role of these downstream
pathways in NGF signaling to cyclin D1. PC12 cells trans-
fected with the -1745CD1LUC reporter were treated with
PD98059, wortmannin, or both in the presence of NGF, and
then they were processed for luciferase assay and Western
blot. Inhibition of the ERK or PI3K pathway reduced NGF-
induced cyclin D1 promoter activity (Figure 6D). Simulta-
neous inhibition of ERK and PI3K pathways (PD98059 
wortmannin) increased this effect, further suggesting that
these pathways independently contribute to NGF signaling
to the cyclin D1 promoter (Figure 6D). Finally, we analyzed
the effects of ERK, p38, and PI3K pathway inhibition on NGF
induction of cyclin D1 protein abundance. Inhibition of the
ERK, p38, or PI3K pathway strongly reduced cyclin D1
induction by NGF (Figure 6E). Interestingly, p38 and PI3K
pathway inhibition reduced the basal ERK activation status
and reduced ERK activation by NGF (Figure 6E, left). To-
gether, these data demonstrate that cyclin D1 induction by
NGF involves the ERK, p38, and PI3K pathways (Figure 6E,
right).
Cyclin D1 Promoter Sequences Involved in Basal and NGF
Responsiveness
To identify the promoter regions that are necessary for NGF-
induced cyclin D1 expression, and to understand the mech-
Figure 6. NGF induction of the cyclin D1
promoter is ERK-independent. (A and B)
PC12 cells were treated with 20 ng/ml NGF
for the time points indicated, and a kinase
assay used to determine ERK and SAPK ac-
tivity. Extracts were immunoprecipitated us-
ing the anti-ERK antibody (ERK2), p42
MAPK, and K-23. Relative -fold induction was
determined by comparison with untreated
cells using densitometry. The data of a repre-
sentative experiment is shown. (Similar re-
sults were obtained using the anti-ERK anti-
body ERK1 C16.) (C) -1745D1LUC stably
transfected PC12 cell line was treated with
different signal transduction pathway inhibi-
tors as indicated, after which the NGF-in-
duced cyclin D1 promoter activity was as-
sessed. The mean data  SEM of n  5
separate transfections are shown. Data were
normalized to the control. (D) -1745D1LUC
stably transfected PC12 cell line was treated
with or without 20 mM PD98059, 10 mM
SB203580, or 200 nM wortmannin, after which
the NGF-induced cyclin D1 promoter activity
was assessed. The mean data  SEM of n  2
separate transfections are shown. (E) Left, cell
lysates from PC12 cells untreated () or
treated with 50 ng/ml NGF () with or with-
out 20 mM PD98059, 10 mM SB203580, or 200
nM wortmannin for 24 h were analyzed by
immunoblotting with specific antibodies for
the indicated proteins. Right, schematic repre-
sentation depicting how the PI3K, ERK, and
p38 pathways collaborate to control NGF in-
duction of cyclin D1 expression.
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anisms that regulate this expression, we generated a series of
5 promoter deletion constructions linked to the luciferase
gene. Transfected PC12 cells were examined for basal and
NGF-regulated activity (Figure 7). Basal elements were iden-
tified between 963 and 420 (Figure 7A). Deletion of the
promoter sequence from 1745 to 163 had no effect on
NGF-induced promoter activity (Figure 7B), whereas dele-
tion from 163 to 22 dramatically reduced NGF-induced
promoter activity (Figure 7B), suggesting that sequence
within the proximal 163 base pairs of the cyclin D1 pro-
moter were involved in NGF-induced activity.
Several promoter elements have been identified within the
proximal 163 base pairs of the cyclin D1 promoter capable
of mediating a response to NGF, including an E2F site (-147),
an Sp1 site (-130), an Egr1 (-117), an LEF (-82) (Figure 7C), an
ATF2 site (-58), or the NF-B site (-39) (Figure 7D). Mutation
or deletion of the E2F site (-147), Sp1 (-130) (Figure 7D),
ATF2 site (-58), and NF-B site (-39) (Figure 7D) reduced
NGF-mediated cyclin D1 promoter activity. Together, these
findings indicate that several sequences within the context of
the native promoter may contribute to NGF responsiveness,
including the E2F, Sp1, NF-B, and the cAMP-response el-
ement/activated transcription factor (CRE/ATF) site.
NGF Induces the Sp1/p107/p50 Transcription Complex in
PC12 Cells
To characterize the complex binding to the cyclin D1 cis
elements required for full NGF responsiveness, EMSA was
performed with untreated or NGF-treated PC12 cell nuclear
extracts. Consistent with the cyclin D1 reporter assay, the
cyclin D1 ATF/CRE site bound a complex in response to
NGF treatment in a time-dependent manner (Figure 8A). We
analyzed E2F binding to the cyclin D1 promoter, but the
relative abundance of E2F complexes was not significantly
altered by NGF at 12 and 24 h (Figure 8B). NGF can mediate
induction of cyclin D1 via transcription factor Sp1 (Yan and
Ziff, 1997); therefore, further studies of the cyclin D1 Sp1 site
were conducted. ChIP assay performed in PC12 cells either
untreated, or treated with NGF, showed that NGF induced
a strong recruitment of Sp1 to the cyclin D1 promoter (Fig-
ure 8C). Sp1 knockdown experiments, conducted in PC12
cells, reduced Sp1 abundance and reduced cyclin D1 induc-
tion by NGF, confirming the functional significance of Sp1 in
NGF-induced cyclin D1 expression (Figure 8D). PC12 cells,
processed for immunoprecipitation with Sp1 antibody, were
subsequently immunoblotted for p107 and p50. Western blot
analyses demonstrated that p107 and p50 associate with Sp1.
Furthermore, NGF increased the association of p50 and p107
with Sp1 (Figure 8F). Together, these findings demonstrate
p107 and p50 associate with Sp1 and that NGF increases p50
and p107 association with Sp1.
NGF Induces Cyclin D1 Promoter Activation and Protein
Expression Through a Sp1/p107/p50 Transcription Complex
Because our studies indicated that NGF treatment of PC12
cells increased the abundance of p107 and p50 to the Sp1
complex, we investigated the role of p107, p50, and Sp1 in
NGF induction of cyclin D1 expression. p50 or p107 siRNA
knockdown in PC12 treated with NGF reduced NGF induc-
tion of cyclin D1 (Figure 9A).
To examine whether p107 or p50 are recruited to Sp1, a
mammalian two-hybrid analysis was conducted. An expres-
Figure 7. Multiple cis elements contribute to the full NGF-responsiveness of the cyclin D1 promoter. Basal (A) and NGF (50 ng/ml for 12 h)
(B)-induced cyclin D1 promoter activities. (C) Schematic representation of the transcription factor binding sites in the -163 proximal cyclin
D1 promoter. NGF-induced promoter activities are shown. (D) The effect of NGF (50 ng/ml for 12 h) on cyclin D1, NF-B, and
ATF-responsive elements by using -66 CD1LUC. The mean data  SEM of nine separate transfections are shown.
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sion vector encoding Gal4-Sp1 was cotransfected with ex-
pression vectors encoding either p107 or p50, together with
a heterologous reporter construct containing 5X Gal4 DNA
binding sites linked to a luciferase reporter gene into PC12
cells. Expression of p107 increased Sp1 activity by 1.3-fold.
NGF treatment induced Sp1 activity threefold, whereas the
E1A binding-defective p107 mutant (Watanabe et al., 1998a)
failed to regulate Sp1 transactivation (Figure 9C). p50 en-
hanced NGF-induced Sp1 activity (Figure 9D). NGF in-
creased p50, but not p107 expression, in a PI3K, ERK and
p38-dependent manner (Figure 10). Thus, the NF-B protein
p50 and the Rb family member p107, under the control of
p21RAS-dependent pathways, enhance the functional inter-
action with Sp1.
DISCUSSION
The current study demonstrates that NGF induction of cy-
clin D1 is required for neurite outgrowth in PC12 cells.
Analysis of the molecular mechanisms by which NGF in-
duces cyclin D1 has identified important roles for Sp1, NF-
B, and p107. Furthermore, these studies present a new
mechanism by which NGF recruits p107 and the NF-B
protein p50 to the Sp1 protein to regulate cyclin D1 expres-
sion. In PC12 cells, cyclin D1 is induced by NGF, in a p21RAS
dependent manner, with delayed early kinetics. p21RAS was
required for induction of cyclin D1 both in transient expres-
sion studies and in the stable RasN17 cell line M-M17-26. In
contrast to cyclin D1, the cyclin A promoter was not induced
by NGF, consistent with previous studies of cyclin A (Buch-
kovich and Ziff, 1994). Our studies indicate that these two
cyclins are subjected to distinct control mechanisms during
PC12 differentiation. NGF-induction of cyclin D1 promoter
activity and protein expression was inhibited by PD98059,
SB203580, wortmannin, or overexpression of dominant-neg-
ative mutants of MEK or ERK but not SEK. Together, these
studies demonstrate that NGF induction of the cyclin D1
promoter involves the p21RAS pathway.
Homozygous deletion of the cyclin D1 gene resulted in
failure of normal retinal development (Fantl et al., 1995;
Sicinski et al., 1995b), and these animals demonstrated ab-
normal neural reflexes, together suggesting a role for cyclin
D1 in normal neural development. Herein, either cyclin D1
antisense or siRNA reduced NGF-induced neurite outgrowth
in PC12 cells, demonstrating a requirement for cyclin D1 in
cellular differentiation. Cyclin D1 regulates differentiation of
myocytes (Skapek et al., 1996) and pregnancy-associated
mammary epithelial cell differentiation (Sicinski et al.,
1995a), suggesting a cellular context specific differentiation
function. In cell type in which the cyclin D1/pRb pathway is
inactivated by large T antigen, cyclin D1 did not contribute
to neurite outgrowth, a function mediated by p35/CDK5
(Xiong et al., 1997).
Cyclin D1 was shown to be induced concordant with
NGF-induced neurite outgrowth in PC12 cells (Yan and Ziff,
1995); however, the molecular mechanisms involved were
previously unknown. In previous studies examining cyclin
D1 expression by proliferative stimuli, basal cyclin D1 ex-
pression was induced through the ERK pathway (Albanese
et al., 1995; Lavoie et al., 1996; Watanabe et al., 1996b). In the
current studies NGF-induced cyclin D1 promoter activity
and protein expression was strongly reduced by chemical
inhibitors of the ERK (PD098059), p38 (SB203580) and PI3K
(wortmannin) pathways, suggesting that p21RAS controls
cyclin D1 expression via ERK, PI3K and p38. Overexpression
of activating ERK mutants induce neurite outgrowth
(Fukuda et al., 1995), the inhibition of p38 blocks NGF-
induced neurite outgrowth (Morooka and Nishida, 1998)
and the PI3K/Akt pathway plays a positive role in PC12
differentiation (Kim et al., 2004). We have therefore hypoth-
esized that each of these pathway may contribute to NGF
induction of cyclin D1 expression and thereby neurite out-
growth. Our studies with chemical inhibitors demonstrate
that p38 inhibition and PI3K inhibition reduced ERK activa-
tion and cyclin D1 expression induced by NGF. These stud-
ies suggest the action of p38 and PI3K pathways may func-
tion through ERK activation.
The genetic response associated with the introduction of
NGF involves sequential induction of immediate early
genes, including c-fos, c-jun (AP-1, AP-1 proteins), and the
orphan nuclear receptor nur77 (Greenberg et al., 1985; Wu et
al., 1989; Yoon and Lau, 1993). A second group of delayed
Figure 8. NGF-induced recruitment of p107 and p50 to the cyclin
D1 Sp1 sequences. The 32P-labeled wild-type cyclin D1 CRE site
probe (A) and cyclin D1 E2F site probe (B) were incubated with
PC12 cell nuclear extracts treated with NGF for the time indicated.
The supershifted complexes are indicated by the asterisk (*). (C)
PC12 cells were treated with 50 ng/ml NGF were used for chroma-
tin immunoprecipitation assay. Sheared chromatin was used to
immunoprecipitate Sp1, and the bound DNA was used as a tem-
plate in a rat cyclin D1-specific PCR. (D) PC12 cells were transfected
with control or Sp1 siRNAs and subsequently treated with 50 ng/ml
NGF for 12 h. Immunoblotting of total lysates was performed using
specific antibodies recognizing the indicated proteins. (E) PC12 cells
were treated with 50 ng/ml NGF for 24 h, after which the nuclear
extract was immunoprecipitated with the Sp1 antibody and subse-
quently blotted for p107 and p50.
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early genes, including the tyrosine hydroxylase gene, is
activated 1–2 h after NGF treatment. This activation is likely
contributed to by the prior induction of AP-1 proteins
(Gizang-Ginsberg and Ziff, 1994). A third class of “late
genes” become active 
18 h after NGF treatment, and they
include genes such as neuron-specific intermediate filament
protein, peripherin, tau-1 and the microtubule-associated
proteins (microtubule-associated protein-1), the expression
of which is enhanced with neurite extension (Drubin et al.,
1985). In the current studies, multiple different sequences
were involved in regulating the cyclin D1 promoter,
whereas the relative abundance of transcription factor
complexes binding to these sequences was increased in
response to NGF treatment. NGF promoted the recruit-
ment of p107 and the NF-B member p50 to an Sp1
complex. NGF enhanced Sp1 transactivation, whereas
mutation of the CRE/ATF site reduced induction by NGF.
CREB/CREM complexes were shown to bind the -58 se-
quences in electrophoretic mobility shift assays per-
formed with PC12 cell nuclear extracts. The p90RSK path-
way induces phosphorylation and activation of CREB,
CREM is required for induction of c-Fos in response to
NGF in PC12 cells (Ginty et al., 1994). Thus, NGF may
induce the cyclin D1 promoter in a p90RSK-dependent
manner through collaborative interactions between sev-
eral different transcription factors which are induced by
p90RSK.
Although cyclin D1 functions as a multimeric holoen-
zyme to phosphorylate and inactivate pRB, it possesses
additional roles. For example, inactivation of the helix-
turn-helix (HLH) protein MyoD occurs independently of
pRB phosphorylation (Skapek et al., 1996). Cyclin D1 has
also been shown to bind additional proteins including
histone deacetylases (HDACs), nuclear receptors, and
transcription factors (Hirai and Sherr, 1996; Fu et al.,
2004). Cyclin D1 inhibits peroxisome proliferator-activated
receptor -mediated adipocyte differentiation through regula-
tion of histone acetyltransferase and histone deacetylase
activity in a CDK-independent manner (Fu et al., 2005a,b),
and it governs heterotypic signals that modulate cellular
migration (Neumeister et al., 2003; Li et al., 2006). NGF-
induced cyclin D1 expression was not associated with an
induction in cyclin D1-immune kinase activity (Buchkovich
and Ziff, 1994) (Pestell and Watanabe, unpublished), sug-
gesting that the effect of cyclin D1 during differentiation of
PC12 cells may, as in myocytes and adipocytes, occur in a
pRB-independent manner. Myocyte differentiation involves
a complex interplay between the abundance of cyclins/
cyclin-dependent kinase inhibitors (CDKIs) (Halevy et al.,
1995; Parker et al., 1995; Skapek et al., 1996), the abundance
and activity of the E2F proteins (Shin et al., 1995), and the
phosphorylation and inactivation of the HLH protein MyoD
(Skapek et al., 1996). Cyclin D1 is capable of modulating
several of these processes, because the activity of E2F-de-
Figure 9. p107, p50, and Sp1 govern cyclin
D1 induction by NGF. (A) Top, PC12 cells
were transfected with control, p50 (left), or
p107 (right) siRNAs and treated with 50
ng/ml NGF for 12 h. Immunoblotting of total
lysates was performed using specific antibod-
ies recognizing the indicated proteins. Bot-
tom, quantification by densitometric analysis
expressed as a normalized value. (B) Sche-
matic representation of Gal4-Sp1 fusion pro-
tein and (UAS)5E1BTATALUC reporter con-
taining 5X Gal4 DNA binding sites. Gal4-Sp1
DNA was cotransfected with expression con-
structs for p107, p107mut (C), or p50 (D) into
PC12 cells. Sp1 activity was assessed by lucif-
erase reporter assay. pCDNA3 and PSG5 rep-
resent the empty expression vector controls
for p107 and p50 expression plasmids, respec-
tively. The mean data  SEM of nine separate
transfections are shown.
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pendent reporters is in part regulated by cyclin D1 and also
MyoD activity is inhibited by cyclin D1 (Skapek et al., 1996).
The CDKI p21CIP1 is induced by NGF in PC12 cells after
8 d (Yan and Ziff, 1995). The induction of cyclin D1
abundance by NGF may be important in regulating down-
stream target genes involved in neurite outgrowth, such
as the CDKIs, or other cyclins, such as p35, which play a
role in cortical neuron outgrowth (Nikolic et al., 1996).
NGF may also promote cyclin D1 association with other
proteins, such as proliferating cell nuclear antigen, in turn
inhibiting their activity and thereby promoting neurite
outgrowth. Last, cyclin D1 induction by NGF may func-
tion to promote phosphorylation of other structural sub-
strates, such as MAP2 or Tau, the normal functions of
which are required for neurite outgrowth; however, the
requirement of cyclin D1 for this activity remains to be
determined.
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